Patent: 6,635,247
✉ Email this page to a colleague
Summary for Patent: 6,635,247
Title: | Hypoparathyroid therapy |
Abstract: | A method for treating hypoparathyroidism and/or hypocalcemia by local administration of a neurotoxin, such as a botulinum toxin, to a parathyroid gland, thereby reducing an inhibitory effect upon parathyroid hormone secretion. A method for treating hyperparathyroidism and/or hypercalcemia by local administration of a neurotoxin, such as a botulinum toxin, to a sympathetic ganglion which innervates a parathyroid hormone secreting parathyroid cell, thereby reducing a stimulatory effect upon parathyroid hormone secretion. |
Inventor(s): | Donovan; Stephen (Capistrano Beach, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 09/835,949 |
Patent Claims: | see list of patent claims |
Details for Patent 6,635,247
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2020-02-22 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |